Burning Rock (NASDAQ: BNR) announced that founder, chairman and CEO Yusheng Han purchased 73,141 ADSs in the open market for US$618,217.72, in compliance with trading rules and the company’s insider policy.
Including prior post-earnings windows, he has acquired 145,874 ADSs for US$1,976,542.90 over three consecutive post-earnings trading windows, which the company views as indicating his confidence in its business and prospects.
Loading...
Loading translation...
Positive
Founder and CEO purchased 73,141 ADSs for US$618,217.72 in open market
Aggregate insider buying of 145,874 ADSs totaling US$1,976,542.90
Purchases spread across three consecutive post-earnings trading windows
Negative
None.
Market reaction after insider share purchase: BNR +9.60% in the Jul 2 session
+9.60%
6 alerts
+9.60%Session close to close
+8.2%Peak in 5 hr 52 min
$107.57MMarket Cap
1.0xRel. Volume
In the Jul 2 session, BNR gained 9.60%, reflecting a notable positive market reaction.
Argus tracked a peak move of +8.2% during that session.
Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
The stock moved +9.6% in the session following this news. A sharp upside move could reflect investor...
Analysis
The stock moved +9.6% in the session following this news. A sharp upside move could reflect investors focusing on the founder’s cumulative 145,874 ADS purchases, reinforcing prior insider buying and low short positioning. Historically, however, strong reactions to similar governance news have been inconsistent.
Key Figures
Latest ADS purchase:73,141 ADSsLatest purchase value:US$618,217.72Prior ADS purchases:72,733 ADSs+2 more
5 metrics
Latest ADS purchase73,141 ADSsOpen-market purchase disclosed in this release
Latest purchase valueUS$618,217.72Cost of 73,141 ADSs bought in open market
Prior ADS purchases72,733 ADSsBought in last two post-earnings trading windows
Aggregate ADS purchases145,874 ADSsTotal across three post-earnings trading windows
Aggregate purchase valueUS$1,976,542.90Total spent across three post-earnings trading windows
Founder and CEO reported substantial open-market ADS buying.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent earnings and governance headlines have more often been followed by weak or negative price reactions, even when fundamentals or insider activity appeared constructive.
Key Terms
next generation sequencing, precision oncology, rule 10b-18, rule 10b5-1
4 terms
next generation sequencingmedical
"focusing on the application of next generation sequencing (NGS) technology"
A collection of advanced laboratory methods that read and map large amounts of DNA or RNA quickly and at lower cost than older techniques; think of it as scanning thousands of pages of a book at once instead of reading one page at a time. Investors care because it accelerates drug development, enables precise diagnostics and personalized treatments, and can create recurring revenue from tests, instruments, and data services as adoption expands.
precision oncologymedical
"NGS technology in the field of precision oncology"
Precision oncology uses detailed biological information from a patient’s tumor—like genetic changes or specific markers—to choose treatments most likely to work for that individual, much like tailoring a suit to a person’s measurements instead of selling one-size-fits-all clothing. It matters to investors because these targeted approaches can improve treatment success, support premium pricing and companion diagnostic tests, and shorten development and approval timelines, creating focused markets with both higher potential returns and specialized risks.
rule 10b-18regulatory
"including the requirements under Rule 10b-18 and Rule 10b5-1"
Rule 10b-18 is a regulation that sets strict rules for how a company's executives and employees can buy back their own company's stock from the market. It helps ensure that these buybacks happen in a fair and transparent way, reducing the chance of market manipulation. This is important for investors because it offers protection against unfair practices and promotes confidence in the integrity of the stock market.
rule 10b5-1regulatory
"including the requirements under Rule 10b-18 and Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
GUANGZHOU, China, July 02, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that its founder, chairman of the board of directors and chief executive officer, Mr. Yusheng Han, has purchased 73,141 of the Company’s ADSs for US$618,217.72 from the open market, which was conducted in compliance with the applicable rules and regulations and the Company’s insider trading policy. As of the date of this press release, combined with 72,733 ADSs purchased in the last two post-earnings trading windows, Mr. Han has purchased an aggregate of 145,874 of the Company’s ADSs for US$1,976,542.90 across three consecutive post-earnings trading windows, indicating his confidence in the Company’s business and prospect.
Mr. Han may continue to purchase the Company’s ADSs through open-market transactions, privately negotiated transactions or block trades, or other legally permissible means, depending on market conditions and in accordance with the applicable rules and regulations.The timing and conditions of Mr. Han’s purchase will be subject to various factors, including the requirements under Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as well as the Company’s insider trading policy.
About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
For more information about Burning Rock, please visit: ir.brbiotech.com.
Contact: IR@brbiotech.com
FAQ
How many Burning Rock (NASDAQ: BNR) ADSs did founder Yusheng Han buy on July 2, 2026?
Yusheng Han bought 73,141 Burning Rock ADSs for US$618,217.72 in open-market transactions. According to Burning Rock, these purchases complied with applicable regulations and the company’s insider trading policy and occurred during a post-earnings trading window.
What is the total value of Burning Rock (BNR) ADSs recently purchased by its founder?
Burning Rock reports that founder Yusheng Han has bought 145,874 ADSs for US$1,976,542.90. According to Burning Rock, these purchases were made across three consecutive post-earnings trading windows through open-market transactions under its insider trading policy.
Does the recent Burning Rock (BNR) insider buying signal confidence in the company?
Burning Rock states that Yusheng Han’s aggregate purchases of 145,874 ADSs indicate his confidence in the business and prospects. According to Burning Rock, these buys occurred over three consecutive post-earnings trading windows in compliant open-market transactions.
Can Burning Rock (NASDAQ: BNR) founder Yusheng Han continue buying ADSs?
Burning Rock indicates that Yusheng Han may continue purchasing ADSs via open-market, privately negotiated, or block trades. According to Burning Rock, any future purchases will depend on market conditions and must comply with applicable regulations and the company’s insider trading policy.
Under which rules are Burning Rock (BNR) insider ADS purchases being conducted?
Burning Rock notes that any ADS purchases by Yusheng Han must follow Rule 10b-18 and Rule 10b5-1 under the Securities Exchange Act of 1934. According to Burning Rock, all transactions also need to comply with the company’s insider trading policy.
